CRIS Current Research Information System

ERCOLANI, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.096
AS - Asia 26.169
EU - Europa 19.159
SA - Sud America 1.583
AF - Africa 1.431
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 9
Totale 75.491
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.681
SG - Singapore 7.125
VN - Vietnam 6.658
CN - Cina 5.961
IT - Italia 4.505
GB - Regno Unito 3.440
DE - Germania 2.532
HK - Hong Kong 2.011
NL - Olanda 1.911
SE - Svezia 1.654
IN - India 1.554
BR - Brasile 1.162
FR - Francia 1.124
RU - Federazione Russa 871
BD - Bangladesh 656
IE - Irlanda 653
UA - Ucraina 611
KR - Corea 537
JP - Giappone 428
FI - Finlandia 412
ZA - Sudafrica 381
CI - Costa d'Avorio 356
CH - Svizzera 354
TG - Togo 260
EE - Estonia 255
CA - Canada 220
BG - Bulgaria 179
AR - Argentina 167
PH - Filippine 164
SC - Seychelles 158
AT - Austria 147
JO - Giordania 146
ID - Indonesia 141
TH - Thailandia 127
MX - Messico 111
IQ - Iraq 101
NG - Nigeria 100
PL - Polonia 93
TR - Turchia 93
BE - Belgio 82
ES - Italia 77
PK - Pakistan 70
EC - Ecuador 68
TW - Taiwan 50
SA - Arabia Saudita 49
CL - Cile 42
GR - Grecia 41
MY - Malesia 40
UZ - Uzbekistan 40
CO - Colombia 39
AU - Australia 38
IR - Iran 38
MA - Marocco 31
VE - Venezuela 31
RO - Romania 30
LT - Lituania 29
PE - Perù 29
HR - Croazia 28
PY - Paraguay 26
LB - Libano 25
AE - Emirati Arabi Uniti 24
EG - Egitto 23
KE - Kenya 20
PT - Portogallo 20
ET - Etiopia 19
IL - Israele 18
NP - Nepal 18
CR - Costa Rica 15
GH - Ghana 15
TN - Tunisia 15
AZ - Azerbaigian 14
JM - Giamaica 14
DZ - Algeria 12
HN - Honduras 12
KZ - Kazakistan 11
UY - Uruguay 11
AL - Albania 10
PS - Palestinian Territory 10
KH - Cambogia 9
MK - Macedonia 9
RS - Serbia 9
CZ - Repubblica Ceca 8
DK - Danimarca 8
LU - Lussemburgo 8
MU - Mauritius 8
DO - Repubblica Dominicana 7
GT - Guatemala 7
HU - Ungheria 7
MD - Moldavia 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
BA - Bosnia-Erzegovina 6
OM - Oman 6
SI - Slovenia 6
BH - Bahrain 5
BO - Bolivia 5
LI - Liechtenstein 5
NI - Nicaragua 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
Totale 75.372
Salva come PNG Salva come JPEG
Città #
Singapore 4.986
Southend 2.958
Ashburn 2.865
Fairfield 2.820
Hong Kong 1.882
Chandler 1.662
San Jose 1.433
Ho Chi Minh City 1.366
Dong Ket 1.321
Woodbridge 1.237
Hanoi 1.124
Santa Clara 1.119
Wilmington 1.111
Hefei 1.053
Seattle 1.009
Houston 973
Cambridge 866
Princeton 785
Beijing 730
Kerkrade 665
Ann Arbor 652
Boardman 615
Dublin 598
Bologna 589
Los Angeles 580
Frankfurt am Main 520
Lauterbourg 443
Seoul 442
Council Bluffs 423
Dallas 408
New York 384
Milan 358
Tokyo 357
Abidjan 356
Munich 339
Eygelshoven 338
Jacksonville 332
Westminster 316
Nanjing 314
Helsinki 305
Padova 264
Lomé 260
Buffalo 250
Delhi 247
Berlin 237
Da Nang 219
Florence 206
Haiphong 204
Bern 201
São Paulo 187
San Diego 174
Jinan 172
Sofia 169
Shenyang 160
Rome 156
Saint Petersburg 149
Guangzhou 145
Amman 141
Redondo Beach 141
Redmond 139
Shanghai 136
Turin 126
Chicago 118
Changsha 116
Menlo Park 112
Bengaluru 108
Nanchang 95
Dearborn 93
Hebei 89
Vienna 89
Amsterdam 88
Tianjin 82
Abeokuta 80
Biên Hòa 80
Nuremberg 80
Jiaxing 79
London 79
The Dalles 79
Johannesburg 76
Des Moines 75
Hangzhou 74
Medford 73
Mülheim 73
Brussels 72
Toronto 72
Orem 70
Phoenix 70
Hải Dương 69
Zhengzhou 69
Falkenstein 66
Montreal 64
Jakarta 62
Warsaw 62
Atlanta 56
Can Tho 55
Olalla 55
Paris 53
Baghdad 51
Bangkok 49
Brooklyn 49
Totale 47.599
Salva come PNG Salva come JPEG
Nome #
Access to and quality of elective care: a prospective cohort study using hernia surgery as a tracer condition in 83 countries 1.809
[Angiogenic factors and their relation to stage, lymph-node micrometastases and prognosis in patients operated on for gastric cancer] 1.635
Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy 583
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 417
Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis 400
Extracorporeal interval support for organ retrieval delivery regional experience with sharing equipe, equipment & expertise to increase conventionally defined as controlled donor pool in time of pandemic 383
Association between multimorbidity and postoperative mortality in patients undergoing major surgery: a prospective study in 29 countries across Europe 368
Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases 352
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 344
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 328
A comprehensive analysis on expected years of life lost due to pancreatic cancer 310
Infected pancreatic necrosis: outcomes and clinical predictors of mortality. A post hoc analysis of the MANCTRA-1 international study 305
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 302
Monofocal hepatocellular carcinoma: How much does size matter? 295
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 288
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 272
Prognostic criteria for postoperative mortality in 170 patients undergoing major right hepatectomy 270
A new liver transplant priority for patients with hepatocellular carcinoma. 266
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 262
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 256
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 256
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. 252
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 249
The Effect of a Liver Transplant Program on the Outcomes of Resectable Hepatocellular Carcinoma: A Nationwide Multicenter Analysis 247
Anticorpi anti-HLA preformati e Trapianto Combinato Rene-Fegato. Caso clinico. 244
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 244
Pattern of macrovascular invasion in hepatocellular carcinoma 242
Surgical therapy for hepatolithiasis: a Western experience. 240
Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. 239
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 237
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 235
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 234
Conventional split liver transplantation for two adult recipients: a recent experience in a single European center 233
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 228
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 226
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 222
Global 30-day morbidity and mortality of surgery for perforated peptic ulcer: GRACE study 221
Resection line involvement after gastric cancer treatment: handle with care 221
GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patients 221
Combined kidney-liver, heart-liver, and kidney-pancreas transplantations from a single deceased donor. 218
Clinical Target Volume in Biliary Carcinoma: A Systematic Review of Pathological Studies. 217
Combined liver–dual kidney transplant: Role in expanded donors 216
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 215
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. 215
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 215
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. 215
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 215
Role of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin 215
Associated benign liver tumors in idiopathic granulomatous hepatitis: a case report 214
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 214
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 212
Assessment of Radiofrequency Ablation Efficacy for Hepatocellular Carcinoma by Histology and Pre-transplant Radiology 212
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 211
Coping strategies in intestinal transplantation 211
Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatment 210
Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation. 210
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 210
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 210
The changing scenario of hepatocellular carcinoma in Italy: an update 209
Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience 208
Abdominal wall defect repair with biological prosthesis in transplanted patients: single center retrospective analysis and review of the literature 207
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 207
Anatomic variations of intrahepatic bile ducts in a European series and meta-analysis of the literature. 206
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 206
Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery 204
Implementation of a patient blood management in an Italian City Hospital: is it effective in reducing the use of red blood cells? 203
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 203
EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones 203
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 203
Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study 202
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients. 202
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 201
Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era. 200
Metabolic disorders across hepatocellular carcinoma in Italy 200
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 200
Years of Life Lost for Older Patients After Colorectal Cancer Diagnosis 198
Radiomic Analysis of Intrahepatic Cholangiocarcinoma: Non-Invasive Prediction of Pathology Data: A Multicenter Study to Develop a Clinical-Radiomic Model 197
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 196
Prognostic significance of tumor doubling time in mass-forming type cholangiocarcinoma. 196
Combined heart-liver transplantation: A single-center experience 196
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 196
Induction therapy with Alemtuzumab (Campath) in combined liver-kidney transplantation: University of Bologna experience. 195
In Reply 195
Combined Liver-Kidney Transplantation With Preformed Anti-HLA Antibodies: A Case Report. 195
Psychological Adaptation and Quality of Life of Adult Intestinal Transplant Recipients: University of Bologna Experience 195
A prospective comparative study between celsior and university of Wisconsin preserving solution in liver transplantation from elderly donors 195
Efficacy of MELD score in predicting survival after liver retransplantation. 194
Gastric splenosis mimicking a gastrointestinal stromal tumor: A case report 194
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors 192
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape: Bertinoro Workshop, November 2022 192
Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin 192
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 192
Discovery of new potentially actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 191
Assessment of perioperative transfusion requirement for cirrhotic patients undergoing elective hepatectomy 190
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. 190
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 189
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 189
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? 188
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 188
A prospective multi-center randomized clinical study to compare the efficacy of ertapenem 3 days versus ampicillin-sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection 187
Totale 26.277
Salva come PNG Salva come JPEG
Categoria #
all - tutte 208.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 208.998
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.034 0 0 0 0 0 0 0 0 0 0 0 2.034
2021/20227.207 652 273 373 523 638 331 163 539 365 370 1.889 1.091
2022/20237.795 724 1.095 419 913 525 590 252 491 1.364 240 735 447
2023/20242.478 192 392 170 269 208 423 148 182 100 169 120 105
2024/202511.909 462 1.521 967 924 1.878 695 863 442 354 789 626 2.388
2025/202630.023 2.084 2.411 2.422 1.894 2.810 3.028 4.077 916 5.375 2.275 1.496 1.235
Totale 76.856